+125.9%
ORCL vs BBIO
+150.9%
-25.0%
-64.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.7% | -2.7% | -3.4% |
| 7D | -2.5% | -2.4% | -0.1% | -2.3% |
| 30D | -10.3% | +15.7% | -26.0% | -11.3% |
| 3M | -21.3% | -3.9% | -17.4% | -21.1% |
| 6M | -40.0% | +16.1% | -56.1% | -40.7% |
| YTD | -40.2% | +0.4% | -40.6% | -40.4% |
| 1Y | -47.0% | +14.8% | -61.8% | -47.7% |
| 3Y | +3.3% | +162.6% | -159.3% | -4.7% |
| 5Y | +29.1% | +66.6% | -37.5% | +10.4% |
| All | +125.9% | +150.9% | -25.0% | +67.5% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling